Andrew J. Pollard

67.5k total citations · 5 hit papers
604 papers, 18.9k citations indexed

About

Andrew J. Pollard is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Andrew J. Pollard has authored 604 papers receiving a total of 18.9k indexed citations (citations by other indexed papers that have themselves been cited), including 271 papers in Epidemiology, 191 papers in Microbiology and 181 papers in Infectious Diseases. Recurrent topics in Andrew J. Pollard's work include Bacterial Infections and Vaccines (189 papers), Pneumonia and Respiratory Infections (185 papers) and Viral gastroenteritis research and epidemiology (98 papers). Andrew J. Pollard is often cited by papers focused on Bacterial Infections and Vaccines (189 papers), Pneumonia and Respiratory Infections (185 papers) and Viral gastroenteritis research and epidemiology (98 papers). Andrew J. Pollard collaborates with scholars based in United Kingdom, United States and Australia. Andrew J. Pollard's co-authors include Else M. Bijker, Dominic F. Kelly, Matthew D. Snape, Ly‐Mee Yu, Manish Sadarangani, Kirsten P. Perrett, David Pace, Peter C. L. Beverley, Mark Jit and Tessa M. John and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Andrew J. Pollard

578 papers receiving 18.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A guide to vaccinology: from basic principles to new developments

2020 900 citations Andrew J. Pollard et al. profile →
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

2021 821 citations Andrew J. Pollard et al. The Lancet profile →
COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II

2020 542 citations Samantha Vanderslott, Ly‐Mee Yu et al. profile →
Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial

2021 192 citations Ly‐Mee Yu, Samantha Vanderslott et al. profile →
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study

2022 115 citations Matthew D. Snape, Simon B. Drysdale et al. profile →

Peers

Countries citing papers authored by Andrew J. Pollard

Since Specialization

Citations

This map shows the geographic impact of Andrew J. Pollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Pollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Pollard more than expected).

Fields of papers citing papers by Andrew J. Pollard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Pollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Pollard. The network helps show where Andrew J. Pollard may publish in the future.

Co-authorship network of co-authors of Andrew J. Pollard

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Pollard. A scholar is included among the top collaborators of Andrew J. Pollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Pollard. Andrew J. Pollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Salmonella Typhi gut invasion drives hypoxic immune subsets associated with disease outcomes 2025 ·Nature Communications ·Noa Bossel Ben‐Moshe, Shelly Hen‐Avivi, (unknown), (unknown), Jennifer Hill, Daniel O’Connor, Marije K. Verheul, Lisa Stockdale, (unknown), Andrew J. Pollard, Roi Avraham	0
2	Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus 2024 ·Nature Communications ·Gu-Lung Lin, Simon B. Drysdale, Matthew D. Snape, Daniel O’Connor, Anthony Brown, George MacIntyre-Cockett, Esther Mellado-Gomez, Mariateresa de Cesare, M. Azim Ansari, David Bonsall, James E. Bray, Keith A. Jolley, Rory Bowden, Jeroen Aerssens, Louis Bont, Peter Openshaw, Federico Martinón‐Torres, Harish Nair, Tanya Golubchik, Andrew J. Pollard	20
3	A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial 2024 ·Vaccine ·Vũ Đình Thiểm, (unknown), (unknown), Hung Thai, Andrew J. Pollard, (unknown), Yukio Tada, (unknown), (unknown), Mari Ariyasu, Takuhiro Sonoyama	1
4	Evaluation of Acute and Convalescent Antibody Concentration Against Pneumococcal Capsular Polysaccharides for the Diagnosis of Pneumococcal Infection in Children with Community-Acquired Pneumonia 2024 ·The Pediatric Infectious Disease Journal ·Michael J. Carter, Sonu Shrestha, Peter O’Reilly, (unknown), Meeru Gurung, Stephen Thorson, Rama Kandasamy, Merryn Voysey, (unknown), Sarah Kelly, (unknown), (unknown), Puja Amatya, Irina Tcherniaeva, Guy A. M. Berbers, David R. Murdoch, Andrew J. Pollard, Shrijana Shrestha, Dominic F. Kelly, (unknown)	0
5	Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines 2023 ·Vaccine ·Christina Dold, (unknown), Laura Silva-Reyes, Luke Blackwell, Aline Linder, Kevin R. Bewley, Kerry Godwin, Susan Fotheringham, Sue Charlton, Young Chan Kim, Andrew J. Pollard, Christine S. Rollier	4
6	The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitudes and expectations in the general public 2023 ·BMJ Open ·Jonathan Kantor, Samantha Vanderslott, Michael Morrison, Andrew J. Pollard, Robert Carlisle	5
7	Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children 2023 ·npj Vaccines ·Dmitri Kazmin, Elizabeth Clutterbuck, Giorgio Napolitani, (unknown), Andrea Tarlton, Amber Thompson, (unknown), (unknown), (unknown), Rachel White, Claire Jones, Matthew D. Snape, Ushma Galal, Ly‐Mee Yu, Rino Rappuoli, Giuseppe Del Giudice, Andrew J. Pollard, Bali Pulendran	9
8	SalmonellaVaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort 2023 ·BMJ Open ·Brama Hanumunthadu, (unknown), Nelly Owino, Carla Ferreira Da Silva, Hannah Robinson, Rachel White, Pietro Ferruzzi, (unknown), Rocı́o Canals, Andrew J. Pollard, Maheshi Ramasamy	10
9	Molecular correlates of vaccine-induced protection against typhoid fever 2023 ·Journal of Clinical Investigation ·(unknown), Irina Chelysheva, (unknown), Luke Blackwell, Celina Jin, Malick M. Gibani, Elizabeth Jones, Jennifer Hill, Johannes Trück, Dominic F. Kelly, Christoph J. Blohmke, Andrew J. Pollard, Daniel O’Connor	4
10	Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers 2022 ·Infection and Immunity ·(unknown), Jennifer Hill, Sagida Bibi, Liye Chen, Claire Jones, Elizabeth Jones, Susana Camara, Sonu Shrestha, Celina Jin, Malick M. Gibani, Hazel Dobinson, Claire S. Waddington, Thomas C. Darton, Christoph J. Blohmke, Andrew J. Pollard	8
11	Homologous and Heterologous Boosting of the Chadox1-S1-S COVID-19 Vaccine With the SCB-2019 Vaccine Candidate: A Randomized, Controlled, Phase 2 Study 2022 ·Open Forum Infectious Diseases ·Sue Ann Costa Clemens, Eveline Pı́polo Milan, Eduardo Sprinz, (unknown), (unknown), Ping Li, Huiling Chen, Igor Smolenov, Andrew J. Pollard, Ralf Clemens	9
12	Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use 2022 ·The Lancet ·(unknown), Ananda S Bandyopadhyay, Andrew J. Pollard	19
13	Potential global impacts of alternative dosing regimen and rollout options for the ChAdOx1 nCoV-19 vaccine 2021 ·Nature Communications ·Ricardo Aguás, (unknown), Lisa J. White, Bo Gao, Andrew J. Pollard, Merryn Voysey, Rima Shretta	7
14	SIMON: Open-Source Knowledge Discovery Platform 2021 ·Patterns ·Adriana Tomić, (unknown), Levi Waldron, Ludwig Geistlinger, Max Kühn, Rachel L. Spreng, (unknown), Kelly E. Seaton, Georgia D. Tomaras, Jennifer Hill, Niharika A. Duggal, Ross D. Pollock, Norman R. Lazarus, Stephen D. R. Harridge, Janet M. Lord, Purvesh Khatri, Andrew J. Pollard, Mark M. Davis	6
15	Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses 2021 ·Science Immunology ·(unknown), Marije K. Verheul, Katherine L. Williams, Celina Jin, Lisa Stockdale, Guy Cavet, Eldar Giladi, Jennifer Hill, Dongkyoon Kim, Yvonne Leung, Benjamin G. Bobay, Leonard D. Spicer, Sheetal Sawant, Sjoerd Rijpkema, S. Moses Dennison, S. Munir Alam, Andrew J. Pollard, Georgia D. Tomaras	9
16	Two centuries of immunisation in the UK (part II) 2019 ·Archives of Disease in Childhood ·Sarah Lang, (unknown), Noel McCarthy, Mary Ramsay, David Salisbury, Andrew J. Pollard	6
17	Non-specific effects of vaccines: plausible and potentially important, but implications uncertain 2017 ·Archives of Disease in Childhood ·Andrew J. Pollard, Adam Finn, Nigel Curtis	86
18	Immunogenicity of booster doses of 13-valent pneumococcal conjugate and Hib/MenC vaccines given at 12 months of age in the UK 2009 ·ePrints Soton (University of Southampton) ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eva Galiza, Daniel A. Scott, Scott D. Patterson, William C. Gruber, (unknown), Saul N. Faust, Adam Finn, Paul T. Heath, Andrew J. Pollard	9
19	A conceptual framework for understanding children as agents in the transition from home to kindergarten 2006 ·Early Years Journal of International Research and Development ·Mei Seung Lam, Andrew J. Pollard	52
20	Meningitis and Meningococcal Septicaemia 1998 ·Journal of the Royal College of Physicians of London ·Andrew J. Pollard, Saul N. Faust, Michael Levin	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact